Recombinant Human DVL2 Protein，His

DVL2, or Dishevelled segment polarity protein 2, is a key component of the Wnt signaling pathway, which is crucial for various cellular processes including cell differentiation, polarity, and proliferation. The Wnt pathway plays a significant role in developmental biology and has been implicated in numerous diseases, including cancer. Research on DVL2 has gained considerable attention because of its involvement in the regulation of signaling cascades that can influence embryonic development and tissue homeostasis. The protein acts as a critical mediator that transduces signals from Wnt ligands to downstream effectors, making it essential for understanding how aberrations in this pathway contribute to pathological conditions. Recombinant DVL2 protein has been produced to facilitate in-depth studies of its structure and function, allowing researchers to investigate its interactions with other proteins, as well as its role in cell signaling. By utilizing advanced techniques such as X-ray crystallography and cryo-electron microscopy, scientists aim to elucidate the molecular mechanisms by which DVL2 operates within the Wnt pathway. Understanding the dynamics of DVL2 not only helps illuminate fundamental biological processes but also holds potential for therapeutic intervention in Wnt-related disorders. Thus, the study of DVL2 and its recombinant forms is a growing field, promising insights into both normal physiology and the underlying mechanisms of diseases linked to Wnt signaling dysregulation.